Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Molecular pathogenesis of human CD59 deficiency

Karbian, Netanel, Eshed-Eisenbach, Yael, Tabib, Adi, Hoizman, Hila, Morgan, B. Paul, Schueler-Furman, Ora, Peles, Elior and Mevorach, Dror 2018. Molecular pathogenesis of human CD59 deficiency. Neurology Genetics 4 (6) , e280. 10.1212/NXG.0000000000000280

[img]
Preview
PDF - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (1MB) | Preview

Abstract

Objective To characterize all 4 mutations described for CD59 congenital deficiency. Methods The 4 mutations, p.Cys64Tyr, p.Asp24Val, p.Asp24Valfs*, and p.Ala16Alafs*, were described in 13 individuals with CD59 malfunction. All 13 presented with recurrent Guillain-Barré syndrome or chronic inflammatory demyelinating polyneuropathy, recurrent strokes, and chronic hemolysis. Here, we track the molecular consequences of the 4 mutations and their effects on CD59 expression, localization, glycosylation, degradation, secretion, and function. Mutants were cloned and inserted into plasmids to analyze their expression, localization, and functionality. Results Immunolabeling of myc-tagged wild-type (WT) and mutant CD59 proteins revealed cell surface expression of p.Cys64Tyr and p.Asp24Val detected with the myc antibody, but no labeling by anti-CD59 antibodies. In contrast, frameshift mutants p.Asp24Valfs* and p.Ala16Alafs* were detected only intracellularly and did not reach the cell surface. Western blot analysis showed normal glycosylation but mutant-specific secretion patterns. All mutants significantly increased MAC-dependent cell lysis compared with WT. In contrast to CD59 knockout mice previously used to characterize phenotypic effects of CD59 perturbation, all 4 hCD59 mutations generate CD59 proteins that are expressed and may function intracellularly (4) or on the cell membrane (2). None of the 4 CD59 mutants are detected by known anti-CD59 antibodies, including the 2 variants present on the cell membrane. None of the 4 inhibits membrane attack complex (MAC) formation. Conclusions All 4 mutants generate nonfunctional CD59, 2 are expressed as cell surface proteins that may function in non–MAC-related interactions and 2 are expressed only intracellularly. Distinct secretion of soluble CD59 may have also a role in disease pathogenesis.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: Wolters Kluwer Health on behalf of the American Academy of Neurology
ISSN: 2376-7839
Date of First Compliant Deposit: 21 October 2020
Date of Acceptance: 7 August 2018
Last Modified: 22 Oct 2020 11:45
URI: http://orca.cf.ac.uk/id/eprint/135837

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics